This functionality is implemented using Javascript. It cannot work without it, etc...

Estamos cargando la información...

Saltar al contenido

Políticas Médicas

Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.

Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.

ID Título Última Revisión Siguiente Revisión Descripción Acceso
11.001.041 Drug Testing In Pain Management And Substance Use Disorder Treatment Dec 09, 2024 Dec 20, 2025 Patients in pain management programs and substance use disorder treatment may misuse prescribed opioids... Ver
11.001.042 Fecal Calprotectin Testing Jan 15, 2025 Jan 20, 2026 Calprotectin is a calcium- and zinc-binding protein that is a potential marker of intestinal inflammation.... Ver
11.001.044 Antigen Leukocyte Antibody Test Nov 15, 2024 Nov 20, 2025 The antigen leukocyte antibody test (alcat) is intended to diagnose intolerance to foods and other... Ver
11.001.046 Maternal Serum Biomarkers for Prediction of Adverse Obstetric Outcomes Mar 20, 2025 Mar 20, 2026 Improved accuracy of the identification of pregnant people at risk of preeclampsia and spontaneous preterm... Ver
11.001.047 Multicancer Early Detection Testing Jul 19, 2024 Jul 20, 2025 Many cancers appear to have a better prognosis if diagnosed early in their natural history. this has led to... Ver
11.002.001 Systems Pathology In Prostate Cancer Dec 10, 2020 Policy Archived Systems pathology, an approach that combines cellular and biologic features to standard clinical parameters,... Ver
11.002.003 Molecular Testing For The Management Of Pancreatic Cysts, Barrett Esophagus, And Solid Pancreaticobiliary Lesions Dec 26, 2024 Dec 20, 2025 Tests that integrate microscopic analysis with molecular tissue analysis are generally called topographic... Ver
11.002.004 Cervical Cancer Screening Technologies With Pap And Hpv Apr 28, 2022 Policy Archived Data suggest that cytologic screening for cervical cancer reduces the incidence of cervical cancer by up to... Ver
11.003.001 Laboratory Tests For Heart And Kidney Transplant Rejection Nov 15, 2024 Nov 20, 2025 Clinical assessment and noninvasive imaging of chronic heart failure can be limited in accurately diagnosing... Ver
11.003.002 Genetic Testing For Predisposition To Inherited Hypertrophic Cardiomyopathy Apr 15, 2024 Apr 20, 2025 Familial hypertrophic cardiomyopathy is an inherited condition caused by a disease associated variant in 1 or... Ver
11.003.003 Multimarker Serum Testing Related To Ovarian Cancer Jan 20, 2025 Jan 20, 2026 A variety of serum biomarkers have been studied for their association with ovarian cancer. of particular... Ver
11.003.004 Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Metastatic Colorectal Cancer (KRAS, NRAS, BRAF, MMR/MSI, HER2, and TMB) Aug 23, 2024 Aug 20, 2025 Summary the epidermal growth factor receptor (egfr) is overexpressed in colorectal cancer (crc).... Ver
11.003.006 Pruebas Genéticas para el Tratamiento Helico Bacter Pylori May 12, 2016 Policy Archived ... Ver
11.003.008 Cytochrome P450 Genotype-Guided Treatment Strategy Jul 17, 2024 Jul 20, 2025 The cytochrome p450 (cyp450) family is involved in the metabolism of many currently administered drugs, and... Ver
11.003.009 Molecular Analysis For Targeted Therapy Of Non-Small-Cell Lung Cancer Dec 05, 2024 Dec 20, 2025 Over half of patients with non-small-cell lung cancer (nsclc) present with advanced and therefore incurable... Ver
11.003.010 Genetic Testing Of Cadasil Syndrome May 16, 2024 May 20, 2025 Variants in the notch3 gene have been causally associated with cerebral autosomal dominant arteriopathy with... Ver
11.003.011 Genetic Testing To Select Melanoma Or Glioma Patients For Targeted Therapy Aug 15, 2024 Jul 20, 2025 The identification of specific, targetable oncogenic “driver mutations” in a subset of melanomas... Ver
11.003.012 Genetic Testing For Inherited Thrombophilia Jun 18, 2024 Jun 20, 2025 Inherited thrombophilias are a group of disorders that predispose individuals to thrombosis. genetic testing... Ver
11.003.013 Genetic Testing For Rett Syndrome Jul 17, 2024 Policy Archived Rett syndrome (rtt), a neurodevelopmental disorder, is usually caused by pathogenic variants in the... Ver
11.003.014 Noninvasive Fetal Rhd Genotyping Using Cell-Free Fetal Dna Sep 12, 2024 Sep 20, 2025 Rhesus d (rhd)-negative women who are exposed to rhd-positive red blood cells can develop anti-rhd... Ver

¿Quieres estar al día con temas sobre salud, noticias, consejos, estilo de vida y más?

¡Suscríbete a nuestro blog para que no te pierdas de nada!

Suscribirse al blog

Queremos personalizar los contenidos de acuerdo a tus preferencias

Por favor selecciona una o más categorias para continuar

¡Gracias por tu suscripción!

Recibirás en tu correo información de tu interés.

787-277-6653 787-474-6326